MODULATION VON CILIOGENESE

European patent · EP3377106 · In force

Register entry

Publication number
EP3377106
Application number
EP16798160
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 17, 2016
Published
Sep 26, 2018
Granted
May 24, 2023
Protection ends at the latest
Nov 16, 2036
Next annual fee due
Nov 30, 2026
IPC classes
A61K 45/00 (2006.01)
A61K 38/17 (2006.01)
A61P 11/00 (2006.01)
Priority
GB 201520258 17.11.2015
PCT application
PCT/EP2016/078075 17.11.2016
PCT publication
WO2017/085225 26.05.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Apr 3, 2024

    Change

    Published in Swissreg on 03.04.2024

  4. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  5. Jun 15, 2023

    Agent entered

    Representative
    Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 15.06.2023

  6. May 24, 2023

    Granted

    Published in Swissreg on 24.05.2023

Parties

Holder

Academisch Ziekenhuis Leiden A/U Leiden University Medical Center

Albinusdreef 2, 2333 ZA Leiden, NL

Agent

Servopatent GmbH

Bühlstrasse 1, 8125 Zollikerberg

Inventor

VAN BREMPT, Ronald Karel Louisa

2300 RC Leiden, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.